Ann: Results of Phase 2 Clinical Trial, page-30

Given the indicative market open percentage drop of 95%, is there any point in selling?

Can anyone tell me if the company has anything, I mean anything going for it at a MCap of $3.05? Is its cash holding more than that, do they have something else in the pipeline, what?

Yes, I know, I should have done my research before diving in the way I did... I thought I had by reading that lengthy bloody broker report.

Aaargh. Selling it seems is pointless. $1,500... may as well piss that away too!